labetalol has been researched along with betadex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prabhu, AA; Rajendiran, N | 1 |
| Chen, B; Chu, C; Fang, L; Lin, T; Tong, S; Xu, P; You, H | 1 |
2 other study(ies) available for labetalol and betadex
| Article | Year |
|---|---|
Encapsulation of labetalol, pseudoephedrine in β-cyclodextrin cavity: spectral and molecular modeling studies.
Topics: Antihypertensive Agents; beta-Cyclodextrins; Capsules; Carbohydrate Conformation; Drug Carriers; Labetalol; Models, Molecular; Pseudoephedrine; Solvents; Spectrometry, Fluorescence; Sympathomimetics | 2012 |
Enantioseparation of five racemic N-alkyl drugs by reverse phase HPLC using sulfobutylether-β-cyclodextrin as a chiral mobile phase additive.
Topics: Atropine; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Fluoxetine; Indicators and Reagents; Labetalol; Stereoisomerism; Venlafaxine Hydrochloride | 2022 |